Journal
CELL
Volume 160, Issue 4, Pages 759-770Publisher
CELL PRESS
DOI: 10.1016/j.cell.2015.01.022
Keywords
-
Categories
Funding
- European Research Council [ERC-2011-StG-280565, ERC-2011-AdG-294678]
- Alexander von Humboldt Foundation/BMBF
- National Center for Competences in Research Synapsy, Synaptic Bases of Mental Health Disease'' Swiss National Science Foundation [3100A0-117816]
Ask authors/readers for more resources
Sensitization of the capsaicin receptor TRPV1 is central to the initiation of pathological forms of pain, and multiple signaling cascades are known to enhance TRPV1 activity under inflammatory conditions. How might detrimental escalation of TRPV1 activity be counteracted? Using a genetic-proteomic approach, we identify the GABA(B1) receptor subunit as bona fide inhibitor of TRPV1 sensitization in the context of diverse inflammatory settings. We find that the endogenous GABAB agonist, GABA, is released from nociceptive nerve terminals, suggesting an autocrine feedback mechanism limiting TRPV1 sensitization. The effect of GABAB on TRPV1 is independent of canonical G protein signaling and rather relies on close juxtaposition of the GABA(B1) receptor subunit and TRPV1. Activating the GABA(B1) receptor subunit does not attenuate normal functioning of the capsaicin receptor but exclusively reverts its sensitized state. Thus, harnessing this mechanism for anti-pain therapy may prevent adverse effects associated with currently available TRPV1 blockers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available